CIK 0001885827 · Non-accelerated filer<br>Emerging growth company
Virax Biolabs Group Ltd
Sign in to watch- Ticker
- VRAX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Mar 31
- Incorporated
- Cayman Islands
- Entity type
- other
- Phone
- 44 020 7788 7414
- Business address
- BIOCITY GLASGOW, BO'NESS ROAD, NEWHOUSE, LANARKSHIRE, United Kingdom, ML1 5UH
- Former names
- Virax Biolabs (Cayman) Ltd
- 6-K Event Report of Foreign Issuer
- 3 Insider Initial Statement of Ownership
- 6-K Event Report of Foreign Issuer
- 424B3 Offering Prospectus
- 6-K Event Report of Foreign Issuer
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- F-3/A Offering F-3/A
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- F-3 Offering F-3
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 20-F Report Annual and Transition Report of Foreign Private Issuers
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
Page 1 of 8 · 159 filings